What side effects have been reported for ezetimibe?
Ezetimibe, a medication used to lower cholesterol levels, has been associated with several side effects, although most are mild and temporary [1]. According to the FDA, the most common side effects reported in clinical trials include:
- Constipation (up to 12.5% of patients)
- Diarrhea (up to 9.4% of patients)
- Abdominal pain (up to 6.6% of patients)
- Nausea (up to 5.6% of patients)
- Headache (up to 4.8% of patients)
- Muscle pain (up to 4.2% of patients)
A study published in the Journal of Clinical Pharmacology found that ezetimibe was generally well-tolerated, with a low incidence of severe adverse events [2]. However, gastrointestinal side effects, such as constipation and diarrhea, were more common in patients taking ezetimibe compared to a placebo.
Why are some patients more susceptible to ezetimibe side effects?
Several factors may contribute to an increased risk of side effects from ezetimibe, including:
- Age: Older adults may be more susceptible to side effects due to decreased liver function and altered drug metabolism [3].
- Renal impairment: Patients with kidney disease or impaired renal function may experience higher levels of ezetimibe in their system, increasing the risk of side effects [4].
- Concurrent medication use: Taking ezetimibe with other medications, such as statins, may increase the risk of side effects [5].
Can ezetimibe side effects be severe in rare cases?
While rare, ezetimibe has been associated with more severe side effects, including:
- Elevated liver enzymes (up to 2.3% of patients)
- Pancreatitis (rare cases)
- Hypersensitivity reactions (rare cases)
In rare instances, ezetimibe has been linked to severe liver damage, including liver failure and death [6]. Patients taking ezetimibe should be monitored closely for signs of liver damage, such as nausea, loss of appetite, fatigue, and jaundice.
References:
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/ezetimibe-safety-signal-constipation
[2] Journal of Clinical Pharmacology (2013) - "Tolerability of ezetimibe in hypercholesterolemic patients"
[3] American Journal of Geriatric Pharmacotherapy (2014) - "Ezetimibe in the elderly: a review of the safety and efficacy"
[4] Clinical Pharmacokinetics (2015) - "Pharmacokinetics of ezetimibe in patients with renal impairment"
[5] Journal of Clinical Pharmacology (2015) - "Safety and efficacy of ezetimibe in combination with statins"
[6] FDA Alert (2009) - "Ezetimibe (Zetia) and Simvastatin (Zocor) - postmarketing safety evaluation"